VORVor BiopharmaRunning, no new patients
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Generalized Myasthenia Gravis
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 191 (final count)
- Started
- Jul 17, 2024
- Main results expected
- Mar 2027
- Fully finished
- Jan 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Change from baseline in Myasthenia Gravis-Activities of Daily Living (MG-ADL) score at Week 24
Measured over: Week 24
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06456580 · record last updated 2026-10-15 · checked 2026-11-09 15:47 UTC